Biotechnology momentum in Canada needs infusion of talent and anchor firms, say industry reps
Canada has several prominent life science firms, but none can be considered an anchor company, according to a report by the adMare Institute released in late 2023.
Canada needs to catch up in the biotech sector
Currently, our scientists have to look outside of the country to take their work to the next level, which means that Canada is not benefitting fully from Canadian ideas.
Unlocking Canada’s greatest economic potential: life sciences
The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can help solve some of our biggest societal challenges.
Canada’s biotech carpe diem
It’s imperative Canada keep pace with other competing jurisdictions, and establish itself as a regulatory leader that rewards investment and talent.
Harnessing the power of Canada’s growing biotechnology industry: a perspective from the West
Government investment and policy can help ensure groundbreaking technologies remain in Canada when companies scale up their production especially for international distribution.
Biotechnology: an opportunity balanced on a knife’s edge
To fully harness the benefits of a thriving biotechnology industry, it is critical we act to address the challenges that threaten it.
Biotechnology must factor into a broader Canadian industrial policy
Governments should focus on supporting basic research, helping startups, and funding the scale-up of growth companies.
Does Canada need a more integrated strategy for pandemic responses? Yes
In the last 20 years, Canada has been hit by several health crises involving variants on known human pathogens and novel viruses arising from animal-to-human transmission. Our sense is that a wider-angle approach in some form merits very serious consideration to better protect Canadians in the next health emergency.
Canada’s biomedical brain drain is reversing. Let’s continue that trend
We must look beyond the lab and build a thriving ecosystem to make sure Canadian biomedical treatments are developed here and benefit Canadians.
Talent shortage a priority for biotech sector emerging from pandemic
Canada is likely to face a shortfall of about 65,000 workers in the bio-economy by 2029, according to BioTalent Canada.
